Authors
Loading...
Randomized controlled trial shows immunonutrients enhance intestinal barrier and gut microbiota in gastric cancer patients, indicating potential therapeutic benefits.
Zheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: